Pfizer, Inc. (NYSE: PFE) Q1 2021 earnings call dated May. 04, 2021 Corporate Participants: Charles E. Triano -- Senior Vice President, Investor Relations Albert
Pfizer, Inc. (PFE) Q1 2021 Earnings Call Transcript

Pfizer, Inc. (NYSE: PFE) Q1 2021 earnings call dated May. 04, 2021 Corporate Participants: Charles E. Triano -- Senior Vice President, Investor Relations Albert
Materialise NV (NASDAQ: MTLS) Q4 2020 earnings call dated Mar. 09, 2021 Corporate Participants: Harriet Fried -- Senior Vice President of LHA Peter Leys -- Executive
Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Mike Hencke — Director, Investor Relations Michel Vounatsos — Chief Executive Officer Alfred
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Q4 2020 earnings call dated Feb. 05, 2021 Corporate Participants: Justin Holko — Vice President, Investor Relations Leonard S.
Merck & Co., Inc. (NYSE: MRK) reported weak earnings and sales for the fourth quarter of 2020. Worldwide sales edged up 5%
Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Mike Hencke -- Director, Investor Relations Michel Vounatsos -- Chief Executive Officer
Abbott (NYSE: ABT) today announced its fourth-quarter financial results for the period ended December 31, 2020. Net earnings for the fourth quarter